These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22544004)

  • 1. Open-label treatment with olanzapine for patients with borderline personality disorder.
    Zanarini MC; Schulz SC; Detke H; Zhao F; Lin D; Pritchard M; Deberdt W; Fitzmaurice G; Corya S
    J Clin Psychopharmacol; 2012 Jun; 32(3):398-402. PubMed ID: 22544004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.
    Zanarini MC; Schulz SC; Detke HC; Tanaka Y; Zhao F; Lin D; Deberdt W; Kryzhanovskaya L; Corya S
    J Clin Psychiatry; 2011 Oct; 72(10):1353-62. PubMed ID: 21535995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P; Rocca P; Uscinska M; Bellino S
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.
    Schulz SC; Zanarini MC; Bateman A; Bohus M; Detke HC; Trzaskoma Q; Tanaka Y; Lin D; Deberdt W; Corya S
    Br J Psychiatry; 2008 Dec; 193(6):485-92. PubMed ID: 19043153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial.
    Shafti SS; Shahveisi B
    J Clin Psychopharmacol; 2010 Feb; 30(1):44-7. PubMed ID: 20075647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine versus placebo in the treatment of borderline personality disorder.
    Bogenschutz MP; George Nurnberg H
    J Clin Psychiatry; 2004 Jan; 65(1):104-9. PubMed ID: 14744178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.
    Schulz SC; Camlin KL; Berry SA; Jesberger JA
    Biol Psychiatry; 1999 Nov; 46(10):1429-35. PubMed ID: 10578457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular olanzapine in patients with borderline personality disorder: an observational study in an emergency room.
    Damsa C; Adam E; De Gregorio F; Cailhol L; Lejeune J; Lazignac C; Allen MH
    Gen Hosp Psychiatry; 2007; 29(1):51-3. PubMed ID: 17189746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
    Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study.
    Stahl SM; Cucchiaro J; Simonelli D; Hsu J; Pikalov A; Loebel A
    J Clin Psychiatry; 2013 May; 74(5):507-15. PubMed ID: 23541189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M; Calabrese JR; Sachs GS; Banov MD; Detke HC; Risser R; Baker RW; Chou JC; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology.
    Zanarini MC; Vujanovic AA; Parachini EA; Boulanger JL; Frankenburg FR; Hennen J
    J Pers Disord; 2003 Jun; 17(3):233-42. PubMed ID: 12839102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
    Kryzhanovskaya L; Schulz SC; McDougle C; Frazier J; Dittmann R; Robertson-Plouch C; Bauer T; Xu W; Wang W; Carlson J; Tohen M
    J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC; Frankenburg FR; Parachini EA
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M; Kryzhanovskaya L; Carlson G; Delbello M; Wozniak J; Kowatch R; Wagner K; Findling R; Lin D; Robertson-Plouch C; Xu W; Dittmann RW; Biederman J
    Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder.
    Soler J; Pascual JC; Campins J; Barrachina J; Puigdemont D; Alvarez E; Pérez V
    Am J Psychiatry; 2005 Jun; 162(6):1221-4. PubMed ID: 15930077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.